VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease

Cannabinoids have shown to exert neuroprotective actions in animal models by acting at different targets including canonical cannabinoid receptors and PPARγ. We previously showed that VCE-003, a cannabigerol (CBG) quinone derivative, is a novel neuroprotective and anti-inflammatory cannabinoid actin...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Alonso, Javier, Paraíso-Luna, Juan, Navarrete, Carmen, del Río, Carmen, Cantarero, Irene, Palomares, Belén, Aguareles, José, Fernández-Ruiz, Javier, Bellido, María Luz, Pollastro, Federica, Appendino, Giovanni, Calzado, Marco A., Galve-Roperh, Ismael, Muñoz, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949444/
https://www.ncbi.nlm.nih.gov/pubmed/27430371
http://dx.doi.org/10.1038/srep29789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949444/
https://www.ncbi.nlm.nih.gov/pubmed/27430371
http://dx.doi.org/10.1038/srep29789

Ejemplares similares